ThermoPCD - Dataverse

Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

51 to 60 of 1,061 Results

5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA. Mar 11, 2025 PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA.", https://doi.org/10.7910/DVN/Y1RNG6, Harvard Dataverse, V1, UNF:6:/6rhFo9ZnnMJObyE2dkzsw== [fileUNF] 5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA. PDBs obtained every 50 ns.
5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA. Mar 11, 2025 PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA.", https://doi.org/10.7910/DVN/OLZAJR, Harvard Dataverse, V1, UNF:6:IKxDajVFyijSbAqhePLL8Q== [fileUNF] 5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA. PDBs obtained every 50 ns.
5X8M, anti-PD-L1 antibody, Durvalumab (298K, 25C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA. Mar 11, 2025 PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (298K, 25C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA.", https://doi.org/10.7910/DVN/IZ6LWE, Harvard Dataverse, V1, UNF:6:zIAV29d0CuEPNZoFp9EZrQ== [fileUNF] 5X8M, anti-PD-L1 antibody, Durvalumab (298K, 25C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA. PDBs obtained every 50 ns.
5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #2 Mar 11, 2025 PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #2", https://doi.org/10.7910/DVN/B1Z1P0, Harvard Dataverse, V1, UNF:6:/6rhFo9ZnnMJObyE2dkzsw== [fileUNF] 5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #2.
5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5C, 500 ns), random seed #2 Mar 11, 2025 PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5C, 500 ns), random seed #2", https://doi.org/10.7910/DVN/4CODOZ, Harvard Dataverse, V1, UNF:6:UXzeDvmZLtFRjkvnPAL1Rg== [fileUNF] 5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5C, 500 ns), random seed #2.
5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #2 Mar 11, 2025 PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #2", https://doi.org/10.7910/DVN/ZON0KX, Harvard Dataverse, V1, UNF:6:IKxDajVFyijSbAqhePLL8Q== [fileUNF] 5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #2.
5X8M, anti-PD-L1 antibody, Durvalumab (298K, 25C, 500 ns), random seed #2 Mar 11, 2025 PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (298K, 25C, 500 ns), random seed #2", https://doi.org/10.7910/DVN/XD8JFK, Harvard Dataverse, V1, UNF:6:zIAV29d0CuEPNZoFp9EZrQ== [fileUNF] 5X8M, anti-PD-L1 antibody, Durvalumab (298K, 25C, 500 ns), random seed #2.
5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA Mar 11, 2025 PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA", https://doi.org/10.7910/DVN/N1OGBY, Harvard Dataverse, V1 5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA. PDBs obtained every 50 ns.
5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA Mar 11, 2025 PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA", https://doi.org/10.7910/DVN/WMPNHB, Harvard Dataverse, V1, UNF:6:9U5CrvSo/QHArmzGoXp7jw== [fileUNF] 5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA. PDBs obtained every 50 ns.
5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA Mar 11, 2025 PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA", https://doi.org/10.7910/DVN/G3HIWN, Harvard Dataverse, V1, UNF:6:+p6iH39sOLvooEiR6u1q7g== [fileUNF] 5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA. PDBs obtained every 50 ns.

5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA.

Mar 11, 2025

PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA.", https://doi.org/10.7910/DVN/Y1RNG6, Harvard Dataverse, V1, UNF:6:/6rhFo9ZnnMJObyE2dkzsw== [fileUNF]

5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA. PDBs obtained every 50 ns.

5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA.

Mar 11, 2025

PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA.", https://doi.org/10.7910/DVN/OLZAJR, Harvard Dataverse, V1, UNF:6:IKxDajVFyijSbAqhePLL8Q== [fileUNF]

5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA. PDBs obtained every 50 ns.

5X8M, anti-PD-L1 antibody, Durvalumab (298K, 25C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA.

Mar 11, 2025

PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (298K, 25C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA.", https://doi.org/10.7910/DVN/IZ6LWE, Harvard Dataverse, V1, UNF:6:zIAV29d0CuEPNZoFp9EZrQ== [fileUNF]

5X8M, anti-PD-L1 antibody, Durvalumab (298K, 25C, 500 ns), random seed #2: RMSD, RMSF, Rg, SASA. PDBs obtained every 50 ns.

5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #2

Mar 11, 2025

PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #2", https://doi.org/10.7910/DVN/B1Z1P0, Harvard Dataverse, V1, UNF:6:/6rhFo9ZnnMJObyE2dkzsw== [fileUNF]

5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #2.

5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5C, 500 ns), random seed #2

Mar 11, 2025

PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5C, 500 ns), random seed #2", https://doi.org/10.7910/DVN/4CODOZ, Harvard Dataverse, V1, UNF:6:UXzeDvmZLtFRjkvnPAL1Rg== [fileUNF]

5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5C, 500 ns), random seed #2.

5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #2

Mar 11, 2025

PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #2", https://doi.org/10.7910/DVN/ZON0KX, Harvard Dataverse, V1, UNF:6:IKxDajVFyijSbAqhePLL8Q== [fileUNF]

5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #2.

5X8M, anti-PD-L1 antibody, Durvalumab (298K, 25C, 500 ns), random seed #2

Mar 11, 2025

PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (298K, 25C, 500 ns), random seed #2", https://doi.org/10.7910/DVN/XD8JFK, Harvard Dataverse, V1, UNF:6:zIAV29d0CuEPNZoFp9EZrQ== [fileUNF]

5X8M, anti-PD-L1 antibody, Durvalumab (298K, 25C, 500 ns), random seed #2.

5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA

Mar 11, 2025

PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA", https://doi.org/10.7910/DVN/N1OGBY, Harvard Dataverse, V1

5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA. PDBs obtained every 50 ns.

5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA

Mar 11, 2025

PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA", https://doi.org/10.7910/DVN/WMPNHB, Harvard Dataverse, V1, UNF:6:9U5CrvSo/QHArmzGoXp7jw== [fileUNF]

5X8M, anti-PD-L1 antibody, Durvalumab (313K, 40C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA. PDBs obtained every 50 ns.

5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA

Mar 11, 2025

PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA", https://doi.org/10.7910/DVN/G3HIWN, Harvard Dataverse, V1, UNF:6:+p6iH39sOLvooEiR6u1q7g== [fileUNF]

5X8M, anti-PD-L1 antibody, Durvalumab (310K, 37C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA. PDBs obtained every 50 ns.

Add Data

Share Dataverse

Link Dataverse

Reset Modifications